Cargando…
Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity
Cancer is one of the leading causes of death in the world. Many strategies of cancer treatment such as radiotherapy which plays a key role in cancer treatment are developed and used nowadays. However, the side effects post-cancer radiotherapy and cancer radioresistance are two major causes of the li...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201854/ https://www.ncbi.nlm.nih.gov/pubmed/30405890 http://dx.doi.org/10.18632/oncotarget.26150 |
_version_ | 1783365584012967936 |
---|---|
author | Assani, Ganiou Xiong, Yudi Zhou, Fuxiang Zhou, Yunfeng |
author_facet | Assani, Ganiou Xiong, Yudi Zhou, Fuxiang Zhou, Yunfeng |
author_sort | Assani, Ganiou |
collection | PubMed |
description | Cancer is one of the leading causes of death in the world. Many strategies of cancer treatment such as radiotherapy which plays a key role in cancer treatment are developed and used nowadays. However, the side effects post-cancer radiotherapy and cancer radioresistance are two major causes of the limitation of cancer radiotherapy effectiveness in the cancer patients. Moreover, reduction of the limitation of cancer radiotherapy effectiveness by reducing the side effects post-cancer radiotherapy and cancer radioresistance is the aim of several radiotherapy-oncologic teams. Otherwise, Telomere and telomerase are two cells components which play an important role in cancer initiation, cancer progression and cancer therapy resistance such as radiotherapy resistance. For resolving the problems of the limitation of cancer radiotherapy effectiveness especially the cancer radio-resistance problems, the radio-gene-therapy strategy which is the use of gene-therapy via modulation of gene expression combined with radiotherapy was developed and used as a new strategy to treat the patients with cancer. In this review, we summarized the information concerning the implication of telomere and telomerase modulation in cancer radiosensitivity. |
format | Online Article Text |
id | pubmed-6201854 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-62018542018-11-07 Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity Assani, Ganiou Xiong, Yudi Zhou, Fuxiang Zhou, Yunfeng Oncotarget Review Cancer is one of the leading causes of death in the world. Many strategies of cancer treatment such as radiotherapy which plays a key role in cancer treatment are developed and used nowadays. However, the side effects post-cancer radiotherapy and cancer radioresistance are two major causes of the limitation of cancer radiotherapy effectiveness in the cancer patients. Moreover, reduction of the limitation of cancer radiotherapy effectiveness by reducing the side effects post-cancer radiotherapy and cancer radioresistance is the aim of several radiotherapy-oncologic teams. Otherwise, Telomere and telomerase are two cells components which play an important role in cancer initiation, cancer progression and cancer therapy resistance such as radiotherapy resistance. For resolving the problems of the limitation of cancer radiotherapy effectiveness especially the cancer radio-resistance problems, the radio-gene-therapy strategy which is the use of gene-therapy via modulation of gene expression combined with radiotherapy was developed and used as a new strategy to treat the patients with cancer. In this review, we summarized the information concerning the implication of telomere and telomerase modulation in cancer radiosensitivity. Impact Journals LLC 2018-10-09 /pmc/articles/PMC6201854/ /pubmed/30405890 http://dx.doi.org/10.18632/oncotarget.26150 Text en Copyright: © 2018 Assani et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Review Assani, Ganiou Xiong, Yudi Zhou, Fuxiang Zhou, Yunfeng Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity |
title | Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity |
title_full | Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity |
title_fullStr | Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity |
title_full_unstemmed | Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity |
title_short | Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity |
title_sort | effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201854/ https://www.ncbi.nlm.nih.gov/pubmed/30405890 http://dx.doi.org/10.18632/oncotarget.26150 |
work_keys_str_mv | AT assaniganiou effectoftherapiesmediatedmodulationoftelomereandortelomeraseoncancercellsradiosensitivity AT xiongyudi effectoftherapiesmediatedmodulationoftelomereandortelomeraseoncancercellsradiosensitivity AT zhoufuxiang effectoftherapiesmediatedmodulationoftelomereandortelomeraseoncancercellsradiosensitivity AT zhouyunfeng effectoftherapiesmediatedmodulationoftelomereandortelomeraseoncancercellsradiosensitivity |